forskolin-stimulated cyclic AMP production
|
|
- Penelope Carpenter
- 6 years ago
- Views:
Transcription
1 Proc. Natl. Acad. Sci. USA Vol. 84, pp , March 1987 Cell Biology a2-adrenergic receptor-mediated sensitization of forskolin-stimulated cyclic AMP production (HT29 cells/uk14,34/desensitization) SUSAN B. JONES, MYRON L. TOEWS, JOHN T. TURNER, AND DAVD B. BYLUND Department of Pharmacology, University of Missouri-Columbia, Columbia, MO Communicated by James. Davis, November 17, 1986 (received for revie August 28, 1986) ABSTRACT Preincubation of HT29 human colonic adenocarcinoma cells ith a2-adrenergic agonists resulted in a 1- to 2-fold increase in forskolin-stimulated cyclic AMP production as compared to cells preincubated ithout agonist. Similar results ere obtained using either a [3H1adenine prelabeling assay or a cyclic AMP radioimmunoassay to measure cyclic AMP levels. This phenomenon, hich is termed sensitization, is a2-adrenergic receptor-mediated and rapid in onset and reversal. Yohimbine, an a2-adrenergic receptor-selective antagonist, blocked norepinephrine-induced sensitization, hereas prazosin (ol-adrenergic) and sotalol (,8-adrenergic) did not. The time for half-maximal sensitization as 5 min and the half-time for reversal as 1 min. Only a 2-fold sensitization of cyclic AMP production stimulated by vasoactive intestinal peptide as observed, indicating that sensitization is relatively selective for forskolin. Sensitization reflects an increased production of cyclic AMP and not a decreased degradation of cyclic AMP, since incubation ith a phosphodiesterase inhibitor and forskolin did not mimic sensitization. ncreasing the levels of cyclic AMP during the preincubation (using a phosphodiesterase inhibitor) had no effect on sensitization, indicating that sensitization is not caused by decreased cyclic AMP levels during the preincubation. This rapid and dramatic sensitization of forskolin-stimulated cyclic AMP production is a previously unreported effect that can be added to the groing list of a2-adrenergic responses that are not mediated by a decrease in cyclic AMP. Activation of several hormone or neurotransmitter receptors leads to inhibition of adenylate cyclase. Examples of these "negatively coupled" receptors include muscarinic cholinergic and somatostatin receptors in AtT-2 mouse pituitary tumor cells and a2-adrenergic receptors in human platelets, NG18-15 neuroblastoma x glioma cells, and HT-29 human colonic adenocarcinoma cells (1-5). The inhibition of adenylate cyclase in these systems is mediated by the guanine nucleotide-binding regulatory protein Ni (6-8). Agonist treatment of various cellular systems can result in a phenomenon called desensitization. Desensitization is a cellular adaptation to agonist treatment that results in a blunting of the physiological response to a subsequent challenge by the agonist. This phenomenon has been studied extensively in several systems that are coupled to stimulation of adenylate cyclase, in particular the,b-adrenergic receptor system (9, 1). Desensitization of the negatively coupled somatostatin and muscarinic cholinergic systems in the AtT-2 cell line has also been reported (1, 11). Desensitization of epinephrine-initiated aggregation of human platelets can occur ithout concomitant don-regulation or desensitization ofthe a2-adrenergic receptor/adenylate cyclase complex (12, 13). The publication costs of this article ere defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance ith 18 U.S.C solely to indicate this fact n addition to desensitization, an increase in forskolinstimulated adenylate cyclase activity folloing somatostatin or muscarinic agonist preincubation has been observed in AtT-2 cells (1, 11). Similar phenomena have been reported for the a2-adrenergic receptor system. Norepinephrine, acting through a2-adrenergic receptors in NG18-15 cells, causes an increased activity of adenylate cyclase after prolonged exposure to the agonist (14). Epinephrine, partly through a2-adrenergic receptors, transiently potentiates forskolin-stimulated cyclic AMP accumulation in isolated rat pancreatic islets but, ith longer incubation, decreases cyclic AMP levels (15). We have examined the effects of agonist preincubation on cyclic AMP synthesis in a human colonic adenocarcinoma cell line, HT29. We report here a pronounced, rapid, and reversible sensitization of forskolin-stimulated cyclic AMP synthesis folloing a2-adrenergic agonist preincubation. MATERALS AND METHODS Cell Culture. HT29 cells, a human colonic adenocarcinoma cell line, ere obtained from J. Fogh (Sloan-Kettering nstitute, Rye, NY). Cells ere gron routinely in Dulbecco's modified Eagle's medium ith high glucose supplemented ith 5% (vol/vol) fetal bovine serum and 5% (vol/vol) neborn bovine serum in 75-cm2 disposable tissue culture flasks in a humidified atmosphere of 5% C2/95% air (5). Cells ere subcultured ith.5% (t/vol) trypsin/.1% (t/vol) Na2EDTA and ere seeded at moderate density in 35-mm tissue culture dishes ith confluence being reached in =5 days. Cyclic AMP Production Assay. Confluent cultures of HT29 cells in 35-mm dishes ere utilized for cyclic AMP assays by a modification of the method of Shimizu et al. (16). All incubations and ashes of cells ere in serum-free Dulbecco's modified Eagle's medium. Cells ere ashed tice ith 2 ml of medium and then prelabeled ith [3H]adenine (5 p.ci per dish; 1 Ci = 37 GBq) ith and ithout agonist and other additions for 3 min at 37 C. The medium as then removed and the cells ere ashed tice ith 2 ml of medium. Cells ere incubated for 2 min ith 1,uM forskolin in 1 ml ith and ithout further additions. At the end of the incubation period, the medium as aspirated and 1 ml of 5% trichloroacetic acid as added. The samples ere then passed sequentially over Doex and alumina columns to isolate cyclic [3H]AMP and [3H]ATP. Each fraction as collected in a scintillation vial to hich 1 ml of Budget Solve (Research Products nternational, Mount Prospect, L) as added. The radioactivity of the samples as determined by standard scintillation spectroscopy ith an efficiency of 35%. Values are expressed as percentage conversion of [3H]ATP to cyclic [3H]AMP {cyclic [3H]AMP/(cyclic [3H]AMP + [3H]ATP)}. Cyclic AMP Radioimmunoassay. Cells ere ashed tice ith 2 ml of medium and then pretreated ith and ithout agonist and other additions in 1 ml of medium for 3 min at 37 C. Cells ere ashed as described above and then 1 ml of
2 Cell Biology: Jones et al. medium ith and ithout 1 /im forskolin as added for a 2-min stimulation. At the end of the stimulation, 1.5 ml of.3 M perchloric acid as added to terminate the reaction. The reaction mixture as neutralized ith 27 tl of 2 M KOH and the samples ere frozen. After centrifugation to remove the precipitate, the cyclic AMP content of the supernatant as measured by radioimmunoassay (17, 18). One of the three radioimmunoassays as performed ith a kit purchased from Ne England Nuclear and the other to ere performed ith antibody kindly provided by Leonard Forte. Materials. (-)-Norepinephrine bitartrate, isoproterenol bitartrate, and yohimbine hydrochloride ere purchased from Sigma. Vasoactive intestinal peptide as purchased from Peninsula Laboratories (Belmont, CA). Forskolin as obtained from Calbiochem-Behring. Dulbecco's modified Eagle's medium as purchased from Kansas City Biologicals (Lenexa, KS), and sera and trypsin ere obtained from GBCO. [3H]Adeninine (4 Ci/mmol) as purchased from CN. The folloing drugs ere graciously donated by the respective companies: prazosin hydrochloride and UK14,34-18 [5-bromo-6-(2-imidazolin-2-amino)quinoxaline] (Pfizer, Groton, CT), sotalol hydrochloride (Bristol-Myers, Evansville, L), 1-propranolol hydrochloride (Ayerst Laboratories, Ne York), and Ro [4-(3-butoxy-4-methoxybenzyl)- 2-imidazolidinedione] (Hoffmann-La Roche Laboratories, Nutley, NJ). RESULTS Forskolin (1,uM) caused a 4-fold increase in cyclic [3H]AMP production by intact HT29 cells prelabeled ith [3H]adenine (Figs. 1 and 2). Norepinephrine and UK14,34, an a2- adrenergic selective agonist, inhibited forskolin-stimulated cyclic AMP production in a dose-dependent manner, indicating that the a2-adrenergic receptor in HT29 cells is negatively coupled to adenylate cyclase (Fig. 1). The maximal inhibition observed in these intact cell assays as >8%, in contrast to 32% maximal inhibition previously observed in membrane adenylate cyclase assays (5). UK14,34, hich decreased cyclic AMP production in intact cells ith an C5 of 3 nm, as more potent than norepinephrine, hich had an C5 of 3 nm. These values are similar to the affinities observed in membrane binding assays for UK14,34 (2 nm) and norepinephrine (47 nm) (5). UK14,34 and norepinephrine inhibited vasoactive intestinal peptide-stimulated cyclic AMP production ith potencies similar to those seen ith forskolin (data not shon). Proc. Natl. Acad. Sci. USA 84 (1987) 1295 Our initial interest as to study the effect of agonist preincubation on desensitization of the a2-adrenergic receptor in HT29 cells. Cells ere preincubated for 3 min ith or ithout norepinephrine prior to assays of cyclic AMP production ith or ithout 1,uM forskolin or 1,uM forskolin and 1,uM norepinephrine. To eliminate possible,b-adrenergic effects of norepinephrine, propranolol (1,uM) as included ith norepinephrine in both phases of the experiment. Agonist preincubation led to a remarkable 2-fold increase in forskolin-stimulated cyclic AMP production (Fig. 2). There as no apparent attenuation of the inhibition of cyclic AMP production by norepinephrine hen the catecholamine as included during the forskolin stimulation step, indicating a lack of desensitization under these conditions. Thus, further studies ere performed to investigate the robust increase in forskolin-stimulated cyclic AMP production folloing agonist preincubation. This phenomenon is referred to as sensitization. Norepinephrine-mediated sensitization as dose dependent ith maximal sensitization occurring at 1,uM (Table 1). To determine hether sensitization as unique to norepinephrine, cells ere preincubated ith UK14,34 (Table 1). The dose response of UK14,34 for mediating sensitization as biphasic, ith a maximal 6-fold sensitization occurring at 1 nm. Since both norepinephrine and UK14,34 have been shon to be full agonists at the a2-adrenergic receptor in these and other cells, an explanation as sought for the eaker biphasic sensitization observed ith UK14,34. A likely possibility as that UK14,34, because of its lipophilicity and high affinity relative to norepinephrine, as retained by the cells folloing preincubation and that the retained UK14,34 inhibited forskolin-stimulated cyclic AMP production during the stimulation step. To test this hypothesis, yohimbine, an a2-adrenergic selective antagonist, as included in the stimulation step to block any inhibition that might occur because of retained agonist. With yohimbine present in the stimulation step, sensitization by UK14,34 preincubation as similar to that seen ith norepinephrine preincubation (Table 2). These data indicate that norepinephrine and UK14,34 are equally efficacious in causing sensitization. One possibility to be considered as that the observed increase in cyclic AMP production as a result of decreased degradation rather than increased synthesis of cyclic AMP. f sensitization ere simply the result of phosphodiesterase inhibition, then maximal inhibition of phosphodiesterase in the incubation ould produce the same (or greater) sensitization as norepinephrine preincubation. To test this hypothesis, a maximally effective concentration (.2 mm) of the O 8,- a -J 2 W 6 4 yw 2 LL C' -. UK 1 4,34-18 N o r e p n e p h r n e FG. 1. Agonist inhibition of forskolin-stimulated cyclic AMP production. Cells ere prelabeled ith 5,uCi of [3H]adenine (in the presence of 1 \um propranolol for norepinephrine inhibition). This medium as removed and 1 ml of 1 um (UK14,34) or 3,uM (norepinephrine) forskolin ith or ithout the indicated concentrations of.... UK14,34 or norepinephrine (plus propranolol) as added. Folloing a 2-min stimulation, cyclic [3H]AMP content as determined. Values are means ± SEM for five experiments. The 1% value for UK14,34 experiments as.12% con version, and for norepinephrine experiments it as.39% conversion. Basal activity (.3% conver- -log [AGC)N S T] M sion) as subtracted from all values. _,. ȧ 2
3 1296 Cell Biology: Jones et al. a- a. +CL -t a. z C,) cn z 2.1L 1.1 ncubation Preincubation _m n. Ba FSK FSK+ NE NE Ba FSK FSK+ NE 1 um NE FG. 2. Effect of norepinephrine (NE) preincubation on forskolin (FSK)-stimulated cyclic AMP production. Cells ere prelabeled ith [3H]adenine ith or ithout 1,uM norepinephrine (plus 1 AM propranolol). Cells ere then incubated ith or ithout 1,uM forskolin ith and ithout 1,.uM norepinephrine plus propranolol for 2 min and cyclic [3H]AMP content'as determined. Values shon are from a representative experiment. Ba, basal. cyclic AMP phosphodiesterase inhibitor Ro as included during the stimulation step. The inclusion of Ro in the stimulation step resulted in only.25% +.6% conversion as compared to 1.28% ±.13% conversion (n = 3) folloing norepinephrine preincubation, indicating that sensitization is not simply a result of decreased phosphodiesterase activity. The onset and reversal of norepinephrine-induced sensitization ere determined as a function of time ofpreincubation (Fig. 3). Sensitization occurred rapidly, ith half-maximal effect after =5 min of preincubation. The maximal response as reached in 1-2 min and as stable for at least 6 min in the continued presence of agonist. Sensitization as rapidly and completely reversible upon removal of the inducing agonist, ith a half-time for reversal of =1 min. The observation that the a2-adrenergic agonist UK14,34, Table 1. Effect of preincubation ith a2-adrenergic agonists on forskolin-stimulated cyclic AMP production in HT29 cells Forskolin-stimulated cyclic AMP production Concentration Norepinephrine UK14,34 1 nm 3.34 ±.15 1 nm 5.96 ±.76 1,uM 4. ± ±.12 1,uM 19.3 ± ±.9 1 JLM 2. ± 4.4 Cells ere prelabeled ith [3H]adenine ith or ithout the indicated concentrations of norepinephrine or UK14,34. Propranolol (1 gm) as included in norepinephrine pretreatments. Cells ere then incubated for 2 min ith 1,uM forskolin and cyclic [3H]AMP content as determined. Values are expressed as -fold increase over forskolin stimulation in the absdnce of agonist preincubation (.17% conversion). Maximal forskolin-stimulated cyclic AMP production folloing norepinephrine preincubation as 3.55% conversion. Values are means ± SEM for three experiments. Table 2. Proc. Natl. Acad. Sci. USA 84 (1987) Effect of including yohimbine during forskolin stimulation of cyclic AMP production in cells preincubated ith UK14,34 Cyclic AMP production UK14,34 Forskolin + concentration Forskolin yohimbine 1 nm 3 ± 9 1 ± 9 1 jam 7 ± 2 17 ± 1 1,UM 3 ± 1 9 ± 16 Cells ere prelabeled ith [3H]adenine ith or ithout the indicated concentrations of UK14,34. Values are percent of response observed ith cells preincubated ith 1 AtM norepinephrine (2.55% conversion). Forskolin-stimulated camp production in cells preincubated ithout agonist as.21% conversion. Values are means ± SEM for three experiments. Yohimbine as 1 AtM. as ell as norepinephrine (plus propranolol), caused sensitization suggested that the effect is mediated by a2-adrenergic receptors. To evaluate further the a2-adrenergic selectivity of the sensitization phenomenon, receptor-selective antagonists ere included in the preincubation (Fig. 4). Sotalol, a P-adrenergic antagonist, and prazosin, an a1-adrenergic antagonist, both had little effect on the sensitization produced by 1 gm norepinephrine. Yohimbine, an a2-adrenergic antagonist, inhibited sensitization completely and in a dosedependent manner. These results confirm that sensitization is mediated by a2-adrenergic receptors. Dose-response curves to forskolin ithout or ith agonist preincubation are presented in Fig. 5. Agonist preincubation resulted in an apparent shift to the left in the dose-response curve to forskolin. Hoever, due to the limited solubility of forskolin, e ere unable to determine hether the maximal response to forskolin as altered by agonist preincubation. To determine hether or not sensitization is unique to forskolin stimulation, the effects of a2-adrenergic agonist J < O - X Ul <: o 8( 6 M 4 zce, 21 cz: z TME, min FG. 3. Time course for induction and reversal of sensitization of forskolin-stimulated cyclic AMP production. For induction, cells ere prelabeled ith [3H]adenine and at appropriate times, either before or during prelabeling, norepinephrine (1 ALM) as added. Folloing prelabeling (3 min) and preincubation (indicated times), 1,uM forskolin as added for 2 min and then cyclic [3H]AMP content as determined. For reversal of sensitization, cells ere preincubated for 3 min ith 1,uM norepinephrine. At appropriate times during or after the preincubation, medium as removed and [3H]adenine as added for 3 min of prelabeling. Prior to and/or during the prelabeling, cells ere incubated for the indicated times in the absence of norepinephrine prior to addition of 1,uM forskolin for 2 min. Cyclic [3H]AMP content as then determined. Results are means SEM for three experiments. Forskolin stimulation in the absence of agonist pretreatment (.17% conversion) has been subtracted. The 1% value as 1.91% conversion
4 Cell Biology: Jones et al. Proc. Natl. Acad. Sci. USA 84 (1987) * +NOREPNEPHRNE NOREPNEPHRNE c O _j O W 6\ YOHMBNE O PRAOSN SOTALOL ) 3. t (L 4 > 1. O log [ANTAGONST], M FG. 4. Effect of antagonists on sensitization of forskolinstimulated cyclic AMP production. Cells ere prelabeled ith [3H]adenine in the presence of 1,uM norepinephrine ith or ithout antagonists at the indicated concentrations. Cells ere then incubated ith 1 MuM forskolin for 2 min and cyclic [3H]AMP content as determined. Values are means ± SEM for three experiments. Forskolin-stimulated cyclic AMP production in the absence of agonist preincubation as.21% conversion. Percentage conversion for preincubation ith norepinephrine in the absence of antagonist (1% value) as 2.23%. preincubation on cyclic AMP production stimulated by other agents ere tested. Stimulation by vasoactive intestinal peptide folloing norepinephrine preincubation as only 1.9 times the stimulation in the absence of norepinephrine preincubation (.72% ±.5% vs..38% ±.6% conversion; n = 3). There as no apparent change in isoproterenolstimulated (,-adrenergic receptor-mediated) cyclic AMP production ith norepinephrine preincubation (.2% ±.1% in both control and norepinephrine preincubated cells; n = 3). Since a2-adrenergic agonist effects traditionally have been thought to result from inhibition of cyclic AMP synthesis, the effects on sensitization of altered levels of cyclic AMP during the preincubation phase ere examined. Table 3 shos the results from experiments in hich the phosphodiesterase inhibitor Ro as included during the preincubation step. n these experiments, cyclic AMP levels ere determined by radioimmunoassay in addition to the standard [3H]adenine prelabeling assay. Cyclic AMP levels ere log [FORSKOLN], M FG. 5. Dose-response curves to forskolin folloing preincubation ithout or ith an a2-adrenergic agonist. Cells ere prelabeled ith [3H]adenine in the absence or presence of 1 MiM norepinephrine ith propranolol. Cells ere then incubated ith the indicated concentrations of forskolin for 2 min and cyclic [3H]AMP content as determined. Values are means ± SEM for six experiments. increased 3-fold in cells preincubated ith norepinephrine and Ro Sensitization occurred in these cells in spite of the fact that cyclic AMP levels ere increased rather than decreased, indicating that sensitization does not result simply from decreased levels of cyclic AMP during the preincubation. The data in Table 3 also demonstrate excellent agreement beteen the results obtained ith the to different assay systems. DSCUSSON a2-adrenergic agonist preincubation of cells could be expected to cause desensitization of the a2-adrenergic receptor, resulting in an attenuation of inhibition of cyclic AMP production upon subsequent challenge ith agonist. Hoever, exposure of HT29 cells to a2-adrenergic agonists led instead to a marked sensitization of forskolin-stimulated cyclic AMP accumulation in intact cells ith no indication of desensitization. This sensitization phenomenon may represent an attempt by the cells to maintain cyclic AMP homeostasis under conditions of prolonged inhibition of adenylate cyclase by the a2-adrenergic agonist. This sensitization phenomenon differs from those reported in AtT-2 cells in at least three ays. First, the magnitude of Table 3. Effect of including Ro during preincubation ith a2-adrenergic agonist on sensitization of forskolin-stimulated cyclic AMP production Radioimmunoassay, [3H]Adenine prelabeling assay, % conversion pmol of cyclic AMP per dish Preincubation Basal Forskolin Basal Forskolin.22 ±.4 (.8).28 ±.12 (9) 4.9 ±.3 (.8) 18.6 ± 2.1 (3) Ro.32 ±.1 (1.).7 ±.26 (22) 5.6 ±.7 (1.) 83 ± 5 (14) NE.3 ±.6 (1.1) 2.2 ±.49 (73) 6.7 ±.9 (1.1) 366 ± 41 (62) NE + Ro.84 ±.25 (2.7) 2.9 ±.49 (1) 12.4 ± 1.6 (2.1) 591 ± 46 (1) Cells ere preincubated in the absence or presence of.25 mm Ro (Ro) and/or 1 MM norepinephrine (NE) as indicated. Cells ere then incubated for 2 min ith or ithout 1 MM forskolin prior to determination of cyclic AMP content by the indicated assays. Values are the means ± SEM for three experiments. Numbers in parentheses are percent of the value for NE + Ro pretreatment folloed by forskolin stimulation.
5 1298 Cell Biology: Jones et al. the sensitization response in HT29 cells as 1- to 2-fold, compared to only a 2- to 4-fold sensitization seen in AtT-2 cells folloing either somatostatin or muscarinic cholinergic agonist preincubation (1, 11). Second, the time course for sensitization in HT29 cells as rapid, ith half-maximal sensitization occurring in -5 min. Muscarinic cholinergic sensitization requires at least 3 hr of agonist preincubation before any effect is observed. The half-maximal effect could not be determined, since at the longest time studied (8 hr) the effect did not appear to be maximal (1). Preincubation ith somatostatin causes maximal sensitization of forskolin-stimulated cyclic AMP production at 16 hr ith half maximal effects seen at 4 hr (11). Third, the sensitization phenomenon observed in AtT-2 cells is blocked by cycloheximide, suggesting that protein synthesis is required for sensitization in these cells. Because of the rapidity of the sensitization response, involvement of protein synthesis in HT29 cell sensitization seems unlikely. Hoever, cycloheximide experiments ill be necessary to sho that protein synthesis is not required for sensitization. The pharmacological data clearly indicate that sensitization is mediated by a2-adrenergic receptors. Yohimbine, an a2-adrenergic-selective antagonist, prevented sensitization hile a1- and p-adrenergic antagonists ere ithout effect. UK14,34, an a2-adrenergic-selective agonist, as considerably more potent than norepinephrine in causing both sensitization and inhibition of forskolin-stimulated cyclic AMP production. Furthermore, 1 nm UK14,34 as maximally effective for both processes, indicating a similar potency of UK14,34 in eliciting both effects. t seemed possible that sensitization might result from a decrease in cyclic AMP degradation (decreased phosphodiesterase activity) rather than from an increase in cyclic AMP synthesis, as previously demonstrated in rat submandibular gland (19). Hoever, the increase in cyclic AMP levels hen phosphodiesterase as maximally inhibited ith Ro during the stimulation step as only 15-2% of that observed in cells preincubated ith a2-adrenergic agonist, indicating that phosphodiesterase inhibition is not the mechanism of sensitization. Furthermore, the relative lack of sensitization of cyclic AMP production stimulated by vasoactive intestinal peptide and isoproterenol indicates that phosphodiesterase is not an important factor in forskolin sensitization. The possibility that sensitization is an artifact of the [3H]adenine prelabeling procedure can be rejected since similar results ere obtained hen cyclic AMP levels ere measured by radioimmunoassay. The mechanism of a2-adrenergic receptor-mediated sensitization of forskolin-stimulated cyclic AMP production is unknon. We tested the hypothesis that decreased levels of cyclic AMP during the a2-adrenergic agonist preincubation ere responsible for sensitization. Our data indicate that this is not the mechanism, since increased cyclic AMP levels did not prevent a2-adrenergic agonist-induced sensitization. Hoever, the inhibitory guanine nucleotide regulatory protein (Ni), or other components of the receptor/cyclase system may be involved in sensitization even if cyclic AMP Proc. Natl. Acad. Sci. USA 84 (1987) itself is not involved. Our results are consistent ith recent literature revieed by Limbird and Seatt (2), hich indicates that although decreasing cyclic AMP levels may be sufficient to elicit a2-adrenergic receptor-mediated responses in some tissues, in other tissues such a signal may be neither necessary nor sufficient. Systems in hich additional or alternative mechanisms are implicated include the secondary aggregation response in human platelets, chloride and ater secretion in endothelial cells, and the a2-adrenergic inhibition of glucose-stimulated insulin release from the pancreas (15, 2, 21). Our results suggest that sensitization can no be added to this list. n summary, e have demonstrated that preincubation of HT29 cells ith an a2-adrenergic agonist causes a marked sensitization of forskolin-stimulated cyclic AMP production, hich is rapid in onset and reversal and is mediated via the a2-adrenergic receptor. Sensitization does not appear to be mediated by decreased cyclic AMP levels and hence another mechanism remains to be elucidated. This ork as supported by Grant HL32931 from the National nstitutes of Health. 1. Heisler, S., Desjardins, D. & Nguyen, M.-H. (1985) J. Pharmacol. Exp. Therap. 232, Reisine, T. & Axelrod, J. (1983) Endocrinology 113, nsel, P. A., Stengel, D., Ferry, N. & Hanoune, J. (1982) J. Biol. Chem. 257, Sabol, S. L. & Nirenberg, M. (1979) J. Biol. Chem. 254, Turner, J. T., Ray-Prenger, C. & Bylund, D. B. (1985) Mol. Pharmacol. 28, Heisler, S. (1985) Biochem. Biophys. Res. Commun. 126, Katada, T., Bokoch, G. M., Smigel, M. D., Ui, M. & Gilman, A. G. (1984) J. Biol. Chem. 259, Kurose, H., Katada, T., Amano, T. & Ui, M. (1983) J. Biol. Chem. 258, Harden, T. K. (1983) Pharmacol. Rev. 35, Sibley, D. R. & Lefkoitz, R. J. (1985) Nature (London) 317, Reisine, T. D. & Takahashi, J. S. (1984) J. Neurosci. 4, Motulsky, H. J., Shattil, S. J., Ferry, N., Rozansky, D. & nsel, P. A. (1986) Mol. Pharmacol. 29, Karliner, J. S., Motulsky, H. J. & nsel, P. A. (1982) Mol. Pharmacol. 21, Sabol, S. L. & Nirenberg, M. (1979) J. Biol. Chem. 254, Ullrich, S. & Wollheim, C. B. (1984) J. Biol. Chem. 259, Shimizu, J., Daly, J. W. & Creveling, C. R. (1969) J. Neurochem. 16, Steiner, A. L., Kipnis, D. M., Utiger, R. & Parker, C. (1969) Proc. Natl. Acad. Sci. USA 64, Harper, J. F. & Brooker, G. (1975) J. Cyclic Nucleotide Res. 1, Bylund, D. B., Forte, L. R., Morgan, D. W. & Martinez, J. R. (1981) J. Pharmacol. Exp. Therap. 218, Limbird, L. E. & Seatt, J. D. (1985) in The Receptors, ed. Conn, P. M. (Academic, Ne York), Vol. 2, pp Nakaki, T., Nakadate, T., Yamamoto, S. & Kato, R. (1983) Mol. Pharmacol. 23,
Cyclic AMP-Mediated Induction of the Cyclic AMP Phosphodiesterase
Proc. Nat. Acad. Sci. USA Vol. 71, No. 1, pp. 3844-3848, October 1974 Cyclic AMP-Mediated nduction of the Cyclic AMP Phosphodiesterase of C-6 Glioma Cells (dibutyryl cyclic AMP/norepinephrine/norepinephrine
More informationpowder and liquid and several laboratory prepared mixes were used in this investigation. The materials used to prepare various
Thermal Analysis During Setting of Zinc Oxide-Eugenol Cements H. M. EL-TAHAWI and R. G. CRAIG School of Dentistry, University of Michigan, Ann Arbor, Michigan 4814, USA Characteristic thermal transitions
More informationNoradrenaline-Sensitive Cyclic AMP-Generating System of Rat Cerebral Cortex with Iron- Induced Epileptiform Activity
Short Communication Japanese Journal of Physiology, 37, 161-167, 1987 Noradrenaline-Sensitive Cyclic AMP-Generating System of Rat Cerebral Cortex with Iron- Induced Epileptiform Activity Yukio HATTORI,
More informationterms of generally assumed pharmacological principles. with the ability to transmit waves of depolarization and force
Proc. Nat. Acad. Sci. USA Vol. 72, No. 3, pp. 824-828, March 1975 Lack of Detectable Change in Cyclic AMP During the Cardiac notropic Response to soproterenol mmobilized on Glass Beads (cat papillary muscles/paired
More informationatively poor response of adenylate cyclase in Leydig cell
Proc. Nati. Acad. Sci. USA Vol. 77, No. 10, pp. 5837-5841, October 1980 Biochemistry Hormone-induced guanyl nucleotide binding and activation of adenylate cyclase in the Leydig cell (hormone action/testicular
More informationBeta-Adrenergic Stimulation of Pineal N-Acetyltransferase: Adenosine
Proc. Nat. Acad. Sci. USA Vol. 72, No. 6, pp. 2107-2111, June 1975 Beta-Adrenergic Stimulation of Pineal : Adenosine 3':5'-Cyclic Monophosphate Stimulates Both RNA and Protein Synthesis (actinomycin D/circadian
More informationcholinergic receptors
Proc. Nati. Acad. Sci. USA Vol. 81, pp. 568-5684, September 1984 Biochemistry Pertussis toxin differentiates between two mechanisms of attenuation of cyclic AMP accumulation by muscarinic cholinergic receptors
More informationsites in turkey erythrocyte membranes [(-)-[3Hjdihydroalprenolol binding/receptor conformation/n-ethylmaleimide/5'-guanylyl imidodiphosphatel
Proc. Nati. Acad. Sci. USA Vol. 77, No. 7, pp. 381-385, July 198 Biochemistry Interaction between f3-adrenergic receptors and guanine nucleotide sites in turkey erythrocyte membranes [(-)-[3Hjdihydroalprenolol
More informationpain" counted as "two," and so forth. The sum of point, the hour point, and so forth. These data are
FURTHER STUDIES ON THE "PHARMACOLOGY" OF PLACEBO ADMINISTRATION 1 BY LOUIS LASAGNA, VICTOR G. LATIES, AND J. LAWRENCE DOHAN (From the Department of Medicine (Division of Clinical Pharmacology), and the
More informationPharmacodynamics. OUTLINE Definition. Mechanisms of drug action. Receptors. Agonists. Types. Types Locations Effects. Definition
Pharmacodynamics OUTLINE Definition. Mechanisms of drug action. Receptors Types Locations Effects Agonists Definition Types Outlines of Pharmacodynamics Antagonists Definition Types Therapeutic Index Definition
More informationCalcium alters the sensitivity of intact horizontal cells to
Proc. Natd Acad. Sci. USA Vol. 79, pp. 335-3354, May 1982 Neurobiology Calcium alters the sensitivity of intact horizontal cells to dopamine antagonists (dopamine receptors/adenylate cyclase/retina) ROBERT
More informationTRANSPORT OF AMINO ACIDS IN INTACT 3T3 AND SV3T3 CELLS. Binding Activity for Leucine in Membrane Preparations of Ehrlich Ascites Tumor Cells
Journal of Supramolecular Structure 4:441 (401)-447 (407) (1976) TRANSPORT OF AMINO ACIDS IN INTACT 3T3 AND SV3T3 CELLS. Binding Activity for Leucine in Membrane Preparations of Ehrlich Ascites Tumor Cells
More informationDrug Receptor Interactions and Pharmacodynamics
Drug Receptor Interactions and Pharmacodynamics Dr. Raz Mohammed MSc Pharmacology School of Pharmacy 22.10.2017 Lec 6 Pharmacodynamics definition Pharmacodynamics describes the actions of a drug on the
More informationGoals and Challenges of Communication. Communication and Signal Transduction. How Do Cells Communicate?
Goals and Challenges of Communication Reaching (only) the correct recipient(s) Imparting correct information Timeliness Causing the desired effect Effective termination Communication and Signal Transduction
More informationPharmacodynamics. Dr. Alia Shatanawi
Pharmacodynamics Dr. Alia Shatanawi Drug Receptor Interactions Sep-17 Dose response relationships Graduate dose-response relations As the dose administrated to single subject or isolated tissue is increased,
More informationInfluences on the density of /3-adrenergic receptors in the cornea and iris-ciliary body of the rabbit
Influences on the density of /3-adrenergic receptors in the cornea and iris-ciliary body of the rabbit Arthur H. Neufeld, Kathleen A. Zatvistowski, Ellen D. Page, and B. Britt Bromberg By measurement of
More information8-Br-cAMP SQ/DDA NKH477 AC IBMX PDE AMP. camp IP 3 R. Control + ESI-09. Control + H89. peak [Ca 2+ ] c (nm) log [PTH(1-34)] (/M) log [PTH(1-34)] (/M)
peak [Ca 2+ ] c peak [Ca 2+ ] c A 8-Br- peak [Ca 2+ ] c peak [Ca 2+ ] c AC IBMX SQ/DDA NKH477 PDE AMP PKA EPAC IP 3 R B 5 + SQ/DDA H89 ESI-9 C 5 + H89 25 25-9 -7-5 log [PTH(1-34)] -9-7 -5 log [PTH(1-34)]
More informationNeurotrophic factor GDNF and camp suppress glucocorticoid-inducible PNMT expression in a mouse pheochromocytoma model.
161 Neurotrophic factor GDNF and camp suppress glucocorticoid-inducible PNMT expression in a mouse pheochromocytoma model. Marian J. Evinger a, James F. Powers b and Arthur S. Tischler b a. Department
More informationthe P-adrenergic receptor in WT cells after N-ethylmaleimide (ii) the decreases that occur in the photolabeled,3-adrenergic
Proc. Natl Acad. Sci. USA Vol. 80, pp. 2849-2853, May 1983 Biochemistry Photoaffinity labeling of the fi-adrenergic receptor from cultured lymphoma cells with [125I]iodoazidobenzylpindolol: Loss of the
More informationCyclic AMP Agonist Inhibition Increases at Low Levels of Histamine Release from Human Basophils1
22-3565/81/2183-642$2OO/O THE Jourai OF PHARMACOLOGY AND EXPERMENTAL ThERAPEUTCS Vol 218, No3 Copyright 1981 by The American Society for Pharmacology and Experimental Therapeutics p,j,,jj j,, Cyclic AMP
More informationCOLLOID DROPLET FORMATION IN DOG THYROID IN VITRO
COLLOID DROPLET FORMATION IN DOG THYROID IN VITRO Induction by Dibutyryl Cyclic-AMP I. PASTAN and S. HI. WOLLMAN. Froml the National Institute of Arthritis and Metabolic Diseases and the National Cancer
More informationGlucose Inhibition of Adenylate Cyclase in Intact Cells of Escherichia coli B (glucose effect/catabolite repression)
Proc. Nat. Acad. Sci. USA Vol. 71, No. 6, pp. 2324-2328, June 1974 Glucose Inhibition of Adenylate Cyclase in Intact Cells of Escherichia coli B (glucose effect/catabolite repression) ALAN PETERKOFSKY
More informationRole of adenosine in drug-induced catatonia in mice
Indian Journal of Experimental Biology Vol. 40, August 2002, pp. 882-888 Role of adenosine in drug-induced catatonia in mice Amanpreet Singh & S K Kulkarni* Pharmacology Division, University Institute
More informationEXTRACELLULAR PROTEINASE OF STREPTOCOCCUS LACTIS'
JOURnNAL OF BACTERIOLOGY Vol. 87, No. 1, pp. 49-53 January, 1964,Copyright 1964 by the American Society for Microbiology Printed in U.S.A. EXTRACELLULAR PROTEINASE OF STREPTOCOCCUS LACTIS' W. T. WILLIAMSON,
More informationFUNDAMENTALS OF BIOCHEMISTRY, CELL BIOLOGY AND BIOPHYSICS Vol. I - Biochemistry of Vitamins, Hormones and Other Messenger Molecules - Chris Whiteley
BIOCHEMISTRY OF VITAMINS, HORMONES AND OTHER MESSENGER MOLECULES Chris Whiteley Department of Biochemistry and Microbiology, Rhodes University, Grahamstown, South Africa Keywords: phosphorylation, phosphorylase,
More informationAlpha Adrenergic Stimulation Reduces Cyclic Adenosine 3,5 -Monophosphate Generation in Rabbit Myometrium by Two Mechanisms
BIOLOGY OF REPRODUCTION 39, 58-65 (1988) Alpha Adrenergic Stimulation Reduces Cyclic Adenosine 3,5 -Monophosphate Generation in Rabbit Myometrium by Two Mechanisms YVONNE Y. WU,3 ALAN GOLDFIEN, and JAMES
More informationA NEW TYPE OF DRUG ENHANCEMENT: INCREASED MAXIMUM RESPONSE TO CUMULATIVE NORADREN- ALINE IN THE ISOLATED RAT VAS DEFERENS
Br. J. Pharmac. Chemother. (1968), 33, 171-176. A NEW TYPE OF DRUG ENHANCEMENT: NCREASED MAXMUM RESPONSE TO CUMULATVE NORADREN- ALNE N THE SOLATED RAT VAS DEFERENS BY A. BARNETT, D. D. GREENHOUSE AND R..
More informationReciprocal Hunger-Regulating Circuits Involving Alphaand
Proceedings of the National Academy of Sciences Vol. 67, No. 2, pp. 1063-1070, October 1970 Reciprocal Hunger-Regulating Circuits Involving Alphaand Beta-Adrenergic Receptors Located, Respectively, in
More informationMonoamine oxidase in sympathetic nerves: a transmitter specific enzyme type
Br. J. Pharmac. (1971), 43, 814-818. Monoamine oxidase in sympathetic nerves: a transmitter specific enzyme type C. GORIDIS AND N. H. NEFF Laboratory of Preclinical Pharmacology, National Institute of
More informationBasics of Pharmacology
Basics of Pharmacology Pekka Rauhala Transmed 2013 What is pharmacology? Pharmacology may be defined as the study of the effects of drugs on the function of living systems Pharmacodynamics The mechanism(s)
More information2401 : Anatomy/Physiology
Dr. Chris Doumen Week 11 2401 : Anatomy/Physiology Autonomic Nervous System TextBook Readings Pages 533 through 552 Make use of the figures in your textbook ; a picture is worth a thousand words! Work
More informationAdenylate cyclase inhibition and GTPase stimulation by somatostatin in S49 lymphoma cyc- variants are prevented by islet-activating protein
Volume 158, number 1 FEBS 0571 July 1983 Adenylate cyclase inhibition and GTPase stimulation by somatostatin in S49 lymphoma cyc- variants are prevented by islet-activating protein Klaus Aktories, Giinter
More informationAutonomic Targets. Review (again) Efferent Peripheral NS: The Autonomic & Somatic Motor Divisions
Review (again) Efferent Peripheral NS: The Autonomic & Somatic Motor Divisions Running Problem: Smoking Homeostasis and the Autonomic Division BP, HR, Resp., H 2 O balance, Temp... Mostly dual reciprocal
More informationReceived July 12,1982; Revised October 28, 1982; Accepted November 10, 1982
0270~6474/83/0304-0725$02.00/O Copyright 0 Society for Neuroscience Printed in U.S.A. The Journal of Neuroscience Vol. 3, No. 4, pp. 725-732 April 1983 ACTIVATION OF P,-ADRENERGIC RECEPTORS ON MOUSE ANTERIOR
More informationDietary saturated triacylglycerols suppress hepatic low density
Proc. Natl. Acad. Sci. USA Vol. 82, pp. 4526-4530, July 1985 Medical Sciences Dietary saturated triacylglycerols suppress hepatic lo density lipoprotein receptor activity in the hamster (cholesterol synthesis/cholesteryl
More informationA comparison of the sensitivities of innervated and denervated rat vasa deferentia to agonist drugs
Br. J. Pharmac. (1970), 39, 748-754. A comparison of the sensitivities of innervated and denervated rat vasa deferentia to agonist drugs A. T. BIRMINGHAM*, G. PATRSON AND J. W6JCICKIt Department of Pharmacology,
More information48 HYPERTENSION VOL 7, No 1, JANUARY-FEBRUARY 1985
48 HYPERTENSON VOL 7, No 1, JANUARY-FEBRUARY 1985 stricter responses were evoked by electrical stimulation of the renal nerves via platinum electrodes with the use of parameters that activate adrenergic
More informationEffect of Sodium Loading and Depletion on Cyclic Nucleotides in Plasma and Aorta. Interaction between Prostacyclin and Cyclic Nucleotides
Endocrinol. Japon. 1982, 29 (2), 245-250 Effect of Sodium Loading and Depletion on Cyclic Nucleotides in Plasma and Aorta. Interaction between Prostacyclin and Cyclic Nucleotides MANABU YOSHIMURA, TERUO
More informationPerformance Testing of a Semi-Hermetic Compressor with HFC-236ea and CFC-114 at Chiller Conditions
Purdue University Purdue e-pubs International Refrigeration and Air Conditioning Conference School of Mechanical Engineering 1994 Performance Testing of a Semi-Hermetic Compressor ith HFC-236ea and CFC-114
More informationENHANCEMENT BY F-ACTIN OF MGATP-DEPENDENT DOPAMINE UPTAKE INTO ISOLATED CHROMAFFIN GRANULES
Vol. 4, No. 1, September 1996 BIOCHEMISTRY and MOLECULAR BIOLOGY INTERNATIONAL Pages 61-66 ENHANCEMENT BY F-ACTIN OF MGATP-DEPENDENT DOPAMINE UPTAKE INTO ISOLATED CHROMAFFIN GRANULES Kyoji Morita ~)*,
More informationPhysiology Unit 1 CELL SIGNALING: CHEMICAL MESSENGERS AND SIGNAL TRANSDUCTION PATHWAYS
Physiology Unit 1 CELL SIGNALING: CHEMICAL MESSENGERS AND SIGNAL TRANSDUCTION PATHWAYS In Physiology Today Cell Communication Homeostatic mechanisms maintain a normal balance of the body s internal environment
More informationEffects of Trypsin on Binding of t3h]epinephrine and t3h]- Dihydroergocryptine to Rat Liver Plasma Membranes
THE JOURNAL OF BOLOGCAL CHEMSTRY Vol. 255, No. 12, ssue of June 25, pp. 5853-5858,1980 Prrnted in U.S.A. Effects of Trypsin on Binding of t3h]epinephrine and t3h]- Dihydroergocryptine to Rat Liver Plasma
More informationAdenosine 3':5'-Cyclic Monophosphate
Proc. Nat. Acad. Sci. USA Vol. 68, No. 4, pp. 786-79, April 1971 Role of the Receptor in the Mechanism of Action of Adenosine 3':5'-Cyclic Monophosphate GORDON N. GLL AND LEONARD D. GARREN Department of
More informationSynopsis. Received March 2, adrenaline. Mosinger and Kujalova (1964) reported that adrenaline-induced lipolysis
Studies on Reduction of Lipolysis in Adipose Tissue on Freezing and Thawing YASUSHI SAITO1, NoBUO MATSUOKA1, AKIRA KUMAGAI1, HIROMICHI OKUDA2, AND SETSURO FUJII3 Chiba University, Chiba 280, Japan, 2Department
More informationProperties of the separated catalytic and regulatory units of brain
Proc. Natl. Acad. Sci. USA Vol. 77, No. 11, pp. 6344-6348, November 1980 Biochemistry Properties of the separated catalytic and regulatory units of brain adenylate cyclase (guanine nucleotide regulation/detergent
More informationLaboratory of Experimental Medicine, Brussels Free University, Brussels, Belgium
Vol. 43, No. 6, December 1997 Pages 1367-1371 BITTER TASTE OF MONOSACCHARIDE PENTAACETATE ESTERS Willy J. MALAISSE and Francine MALAISSE-LAGAE Laboratory of Experimental Medicine, Brussels Free University,
More informationThe binding characteristics of these sites have resembled, in
Proc. Nat. Acad. Sci. USA Vol. 72, No. 4, pp. 1561568, April 1975 Identification of Cardiac f3-adrenergic Receptors by (-) [3H]Alprenolol Binding* (stereospecificity/binding kinetics/ft-adrenergic agonists/36-adrenergic
More informationChapter 20. Cell - Cell Signaling: Hormones and Receptors. Three general types of extracellular signaling. endocrine signaling. paracrine signaling
Chapter 20 Cell - Cell Signaling: Hormones and Receptors Three general types of extracellular signaling endocrine signaling paracrine signaling autocrine signaling Endocrine Signaling - signaling molecules
More informationVets 111/Biov 111 Cell Signalling-2. Secondary messengers the cyclic AMP intracellular signalling system
Vets 111/Biov 111 Cell Signalling-2 Secondary messengers the cyclic AMP intracellular signalling system The classical secondary messenger model of intracellular signalling A cell surface receptor binds
More informationto the change in the fraction of receptor binding sites occupied as a result of the stimulus (9). Thus,- the response reflects the
Proc. Natl. Acad. ci. UA Vol. 74, No. 11, pp. 49644968, November 1977 Biochemistry ensory transduction in Escherichia coli: Role of a protein methylation reaction in sensory adaptation (bacterial chemotaxis/protein
More informationAmphibian oocyte maturation and protein synthesis: Related
Proc. Nati. Acad. Sci. USA Vol. 75, No. 3, pp. 1242-1246, March 1978 Biochemistry Amphibian oocyte maturation and protein synthesis: Related inhibition by cyclic AMP, theophylline, and papaverine (hormone
More informationDopamine-Sensitive Adenylate Cyclase in Caudate Nucleus of Rat Brain,
Proc. Nat. Acad. Sci. USA Vol. 69, No. 8, pp. 2145-2149, August 1972 Dopamine-Sensitive Adenylate Cyclase in Caudate Nucleus of Rat Brain, and Its Similarity to the "Dopamine Receptor" (extrapyramidal
More informationChapter 6 Communication, Integration, and Homeostasis
Chapter 6 Communication, Integration, and Homeostasis About This Chapter Cell-to-cell communication Signal pathways Novel signal molecules Modulation of signal pathways Homeostatic reflex pathways Cell-to-Cell
More informationBiol220 Cell Signalling Cyclic AMP the classical secondary messenger
Biol220 Cell Signalling Cyclic AMP the classical secondary messenger The classical secondary messenger model of intracellular signalling A cell surface receptor binds the signal molecule (the primary
More informationBy the name of Allah
By the name of Allah Receptors function and signal transduction ( Hormones and receptors Types) We were talking about receptors of the neurotransmitters; we have 2 types of receptors: 1- Ionotropic receptors
More informationReceptors and Drug Action. Dr. Subasini Pharmacology Department Ishik University, Erbil
Receptors and Drug Action Dr. Subasini Pharmacology Department Ishik University, Erbil Receptors and Drug Action Receptor Receptor is defined as a macromolecule or binding site located on the surface or
More informationClose to site of release (at synapse); binds to receptors in
Chapter 18: The Endocrine System Chemical Messengers 1. Neural 2. Endocrine 3. Neuroendocrine 4. Paracrine 5. Autocrine Endocrine System --Endocrine and nervous systems work together --Endocrine vs. Nervous
More informationBIOLOGY - CLUTCH CH.45 - ENDOCRINE SYSTEM.
!! www.clutchprep.com Chemical signals allow cells to communicate with each other Pheromones chemical signals released to the environment to communicate with other organisms Autocrine signaling self-signaling,
More informationPlasma free fatty acid and blood glucose responses
J. Lipid Researoh. April, Volume. Number Plasma free fatty acid and blood glucose responses to analogues of norepinephrine in man PETER S. MUELLER and DAVD HORWTZ Laboratory of Clinical Science, National
More informationPTH increases renal 25(OH)D 3-1 -hydroxylase (CYP1 ) mrna but not renal 1,25(OH) 2 D 3 production in adult rats
Am J Physiol Renal Physiol 284: F1032 F1036, 2003; 10.1152/ajprenal.00306.2002. PTH increases renal 25(OH)D 3-1 -hydroxylase (CYP1 ) mrna but not renal 1,25(OH) 2 D 3 production in adult rats H. J. Armbrecht,
More informationGeneral Principles of Endocrine Physiology
General Principles of Endocrine Physiology By Dr. Isabel S.S. Hwang Department of Physiology Faculty of Medicine University of Hong Kong The major human endocrine glands Endocrine glands and hormones
More informationHistamine Develops Homologous Desensitization under Ca 2+ -free Conditions with Increase in Basal Tone in Smooth Muscle of Guinea Pig Taenia Caeci
YAKUGAKU ZASSHI 130(3) 451 455 (2010) 2010 The Pharmaceutical Society of Japan 451 Notes Histamine Develops Homologous Desensitization under Ca 2+ -free Conditions with Increase in Basal Tone in Smooth
More informationChp. 17 FUNCTIONAL ORG. Char.of the Endocrine System
Chp. 17 FUNCTIONAL ORG. Char.of the Endocrine System Glands that secrete chemical signals (hormones) into circulatory system Hormone characteristics Produced in small quantities Secreted into intercellular
More informationRevision. General functions of hormones. Hormone receptors. Hormone derived from steroids Small polypeptide Hormone
االله الرحمن الرحيم بسم Revision General functions of hormones. Hormone receptors Classification according to chemical nature Classification according to mechanism of action Compare and contrast between
More informationLast updated Glycogen synthesis, glycogenolysis, and gluconeogenesis in primary mouse hepatocytes
Last updated 2011-03-02 Glycogen synthesis, glycogenolysis, and gluconeogenesis in primary mouse hepatocytes Media Formulations A. Media for glycogen synthesis: Culture medium base: DMEM-Low (Mediatech/Cellgro
More informationChapter-13. Hormones and Signal Transduction. Page /8/2017 Dr. Amjid Iqbal PhD (University of Cambridge) 1
Chapter-13 Hormones and Signal Transduction Page 396-401 Dr. Amjid Iqbal PhD (University of 1 Living things coordinate their activities through biochemical signaling system Intercellular signals are mediated
More informationAntibodies Produced by Rabbits Immunized
INFECTION AND IMMUNITY, Dec. 1971, p. 715-719 Copyright 1971 American Society for Microbiology Vol. 4, No. 6 Printed in U.S.A. Antibodies Produced by Rabbits Immunized ith Visna Virus SEUNG C. KARL AND
More informationMETHEMOGLOBIN BLOCKADE OF CORONARY ARTERIAL SOLUBLE GUANYLATE CYCLASE ACTIVATION BY NITROSO COMPOUNDS AND ITS REVERSAL WITH DITHIOTHREITOL
METHEMOGLOBIN BLOCKADE OF CORONARY ARTERIAL SOLUBLE GUANYLATE CYCLASE ACTIVATION BY NITROSO COMPOUNDS AND ITS REVERSAL WITH DITHIOTHREITOL Eliot H. OHLSTEIN, Barbara K. BARRY, Darlene Y. GRUETTER and Louis
More informationUrea Transport in Saccharomyces cerevisiae
JOURNAL OF BACTERIOLOGY, Feb. 1975, p. 571-576 Vol. 121, No. 2 Copyright i 1975 American Society for Microbiology Printed in U.S.A. Urea Transport in Saccharomyces cerevisiae TERRANCE G. COOPER* AND ROBERTA
More information2402 : Anatomy/Physiology
Dr. Chris Doumen Lecture 2 2402 : Anatomy/Physiology The Endocrine System G proteins and Adenylate Cyclase /camp TextBook Readings Pages 405 and 599 through 603. Make use of the figures in your textbook
More informationLippincott Questions Pharmacology
Lippincott Questions Pharmacology Edition Two: Chapter One: 1.Which one of the following statements is CORRECT? A. Weak bases are absorbed efficiently across the epithelial cells of the stomach. B. Coadministration
More informationHAEMOLYTIC DISEASE OF THE NEWBORN
SERUM ENZYME CTVTY N PREMTURTY ND N HEMOLYTC DSESE OF THE NEWBORN BY M. BREND MORRS and J. KNG From the Paediatric and Pathology Departments, North Lonsdale Hospital, the Barro and Furness Hospital Group
More informationSupporting Information
Supporting Information Burford et al. 1.173/pnas.1339311 SI Materials and Methods β-arrestin Recruitment Assay. PathHunter human osteosarcoma cells (U2OS) expressing either μ-opioid receptors (U2OS- OPRM1)
More informationEFFECTORS IMPLICATED IN THE AC1 INHIBITORY EFFECT ON CELL PROLIFERATION IN PANCREATIC CANCER CELLS
EFFECTORS IMPLICATED IN THE AC1 INHIBITORY EFFECT ON CELL PROLIFERATION IN PANCREATIC CANCER CELLS VIDYA MEDEPALLI ADVISOR: Maria Eugenia Sabbatini, PhD PHI KAPPA PHI RESEARCH CONFERENCE MARCH 18 TH, 2016
More informationPharmacodynamics. Prof. Dr. Öner Süzer Cerrahpaşa Medical Faculty Department of Pharmacology and Clinical Pharmacology
Pharmacodynamics Prof. Dr. Öner Süzer Cerrahpaşa Medical Faculty Department of Pharmacology and Clinical Pharmacology www.onersuzer.com Last updated: 13.05.2010 English Pharmacology Textbooks 2 2 1 3 3
More informationStimulation by Dopamine of Adenylate Cyclase in Retinal Homogenates and of Adenosine-3':5'-Cyclic Monophosphate Formation in Intact Retina
Proc. Nat. Acad. Sci. USA Vol. 69, No. 3, pp. 539-543, March 1972 Stimulation by Dopamine of Adenylate Cyclase in Retinal Homogenates and of Adenosine-3':5'-Cyclic Monophosphate Formation in Intact Retina
More informationAccepted for publication February 10, 1986
22-3565/86/2373-72$OO.OO/O THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS Copyright (C) 1986 by The American Society for Pharmacology and Experimental Therapeutics Vol 237, No.3 Printed in USA
More informationINTERACTION DRUG BODY
INTERACTION DRUG BODY What the drug does to the body What the body does to the drug Receptors - intracellular receptors - membrane receptors - Channel receptors - G protein-coupled receptors - Tyrosine-kinase
More informationDependent Chemiluminescence Response and Bacterial Susceptibility to Phagocytosis
INFECTION AND IMMUNITY, Nov. 198, p. 37-374 19-9567/8/11-37/5$2./ Vol. 3, No. 2 Correlation Beteen Measurements of the Luminol- Dependent Chemiluminescence Response and Bacterial Susceptibility to Phagocytosis
More informationAutonomic Nervous System
ANS..??? Autonomic Nervous System Nervous system CNS PNS Autonomic Somatic Symp Parasymp Enteric SOMATIC AUTONOMIC Organ supplied Skeletal muscle Other organs Distal most synapse Nerve fibre Peripheral
More informationGENERAL CHARACTERISTICS OF THE ENDOCRINE SYSTEM FIGURE 17.1
GENERAL CHARACTERISTICS OF THE ENDOCRINE SYSTEM FIGURE 17.1 1. The endocrine system consists of glands that secrete chemical signals, called hormones, into the blood. In addition, other organs and cells
More informationMonday, 7 th of July 2008 ( ) University of Buea MED30. (GENERAL ENDOCRINOLOGY) Exam ( )
.. Monday, 7 th of July 2008 (8 30-11. 30 ) Faculty of Health Sciences University of Buea MED30 304 Programme in Medicine (GENERAL ENDOCRINOLOGY) Exam (2007-2008).. Multiple Choice Identify the letter
More informationnorepinephrinee." 2 PNMT activity is stimulated by certain adrenocortical markedly,3' 4 but can be restored to normal by the administration of
IMPAIRED SECRETION OF EPINEPHRINE IN RESPONSE TO INSULIN AMONG HYPOPHYSECTOMIZED DOGS* BY RICHARD J. WURTMAN, ALFRED CASPER, LARISSA A. POHORECKY, AND FREDERIC C. BARTTER DEPARTMENT OF NUTRITION AND FOOD
More informationInhibition of Antibody Secretion by 5-Aminosalicylic Acid
GASTROENTEROLOGY 1989;96:442-8 Inhibition of Antibody Secretion by 5-Aminosalicylic Acid RICHARD P. MACDERMOTT, SUANNE R. SCHLOEMANN, MICHAEL J. BERTOVICH, GEOFFREY S. NASH, MARION PETERS, and WILLIAM
More informationrevzew Adrenergic regulation of ad i pocyte meta bo1 ism John N. Fain and J. Adolfo Garcia-Siinz*
revzew Adrenergic regulation of ad i pocyte meta bo1 ism John N. Fain and J. Adolfo Garcia-Siinz* Section of Biochemistry, Division of Biology and Medicine, Brown University, Providence, RI 0291 2, and
More informationKey words: Collagen synthesis - N-Terminal peptide of type III procollagen - Tumor marker - Liver cancer - Liver cirrhosis
[Gann, 75, 130-135; February, 1984] HIGH CONCENTRATIONS OF N-TERMINAL PEPTIDE OF TYPE III PROCOLLAGEN IN THE SERA OF PATIENTS WITH VARIOUS CANCERS, WITH SPECIAL REFERENCE TO LIVER CANCER Terumasa HATAHARA,
More informationSerotonin-stimulated cyclic AMP synthesis in the rabbit corneal epithelium
Serotonin-stimulated cyclic AMP synthesis in the rabbit corneal epithelium Arthur H. Neufeld, Sally. Ledgard, Marcia M. Jumblatt, and Stephen D. Klyce* Serotonin increases the level of cyclic AMP in incubated
More informationBiology of the Salivary Glands 513 (KEY) MID-TERM Examination May 23, 2001
Multiple Choice Biology of the Salivary Glands 513 (KEY) MID-TERM Examination May 23, 2001 1. Pilocarpine inhibits secretion more than propranolol because: a. It is a cholinergic agonist and therefore
More informationRESPONSES TO AMINES IN VASCULAR TISSUE
Br. J. Pharmac. (197), 3, 267-277 ROLE OF EXTRANEURONAL MECHANISMS IN THE TERMINATION OF CONTRACTILE RESPONSES TO AMINES IN VASCULAR TISSUE S. KALSNER Department of Pharmacology, Faculty of Medicine, University
More informationCholera Toxin Mimics Melanocyte Stimulating Hormone in Inducing
Proc. Nat. Acad. Sci. USA Vol. 71, No. 6, pp. 25-25, June 197 Cholera Toxin Mimics Melanocyte Stimulating Hormone in nducing Differentiation in Melanoma Cells (adenylate cyclase/membrane receptors/tyrosinase/morphology/cell
More informationAmino Acid Control of Autophagic Sequestration and Protein Degradation in Isolated Rat Hepatocytes
Published Online: 1 August, 1984 Supp Info: http://doiorg/1183/jcb992435 Donloaded from jcbrupressorg on September 2, 218 Amino Acid Control of Autophagic Sequestration and Protein Degradation in Isolated
More informationDiscover Activity. Think It Over Inferring Do you think height in humans is controlled by a single gene, as it is in peas? Explain your answer.
Section Human Inheritance Reading Previe Key Concepts What are some patterns of inheritance in humans? What are the functions of the sex chromosomes? What is the relationship beteen genes and the environment?
More informationPsych 181: Dr. Anagnostaras
Psych 181: Dr. Anagnostaras Lecture 5 Synaptic Transmission Introduction to synaptic transmission Synapses (Gk., to clasp or join) Site of action of most psychoactive drugs 6.5 1 Synapses Know basic terminology:
More informationJournal of Experimental Microbiology and Immunology (JEMI) Vol. 9:6-10 Copyright April 2006, M&I, UBC
The Effect of Cyclic 3, 5 -Adenosine Monophosphate on the Effect of Glucose, Fructose, and Sucrose Supplements on the Induction of lacz in Escherichia coli B23 Grown in Minimal Medium with Glycerol JOSHUA
More informationProduct # R8132 (Explorer Kit) R8133 (Bulk Kit)
Product Insert QBT Fatty Acid Uptake Assay Kit Product # R8132 (Explorer Kit) R8133 (Bulk Kit) Introduction About the Fatty Acid Uptake Assay Kit The homogeneous QBT Fatty Acid Uptake Assay Kit from Molecular
More informationAdenylyl Cyclase Supersensitivity in Opioid-Withdrawn NG Hybrid Cells Requires G s but Is Not Mediated by the G s Subunit
0022-3565/98/2862-0855$03.00/0 THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS Vol. 286, No. 2 Copyright 1998 by The American Society for Pharmacology and Experimental Therapeutics Printed in
More informationTala Saleh. Ahmad Attari. Mamoun Ahram
23 Tala Saleh Ahmad Attari Minna Mushtaha Mamoun Ahram In the previous lecture, we discussed the mechanisms of regulating enzymes through inhibitors. Now, we will start this lecture by discussing regulation
More informationby rheumatoid sera and synovial fluid
Annals of the Rheumatic Diseases, 1983, 42, 158-162 Direct activation of neutrophil chemiluminescence by rheumatoid sera and synovial fluid R. GALE, J. V. BERTOUCH, J. BDLEY, AND P. J. ROBERTS-THOMSON
More informationMouse GLP-2 EIA FOR LABORATORY USE ONLY
YK142 Mouse GLP-2 EIA FOR LABORATORY USE ONLY Kasumigaseki place, 3-6-7, Kasumigaseki, Chiyoda-ku, Tokyo 100-0013 Japan http://www.sceti.co.jp/english/export e-mail exp-pet@sceti.co.jp
More informationCell Signaling (part 1)
15 Cell Signaling (part 1) Introduction Bacteria and unicellular eukaryotes respond to environmental signals and to signaling molecules secreted by other cells for mating and other communication. In multicellular
More information